NZD/USD fills the week-start gap above 0.6900 on upbeat New Zealand Q3 Retail Sales

  • NZD/USD takes the bids after a big positive beat of the NZ Retail Sales.
  • New Zealand data crossed downbeat forecasts amid recovery from coronavirus-led activity restrictions in Q3.
  • Trading sentiment struggles amid fears of a brake to the Fed’s emergency lending programs, covid resurgence.
  • November month PMIs become the key data, risk catalysts shouldn’t be ignored.

NZD/USD rises to 0.6930 during the initial hour of Monday’s Asian trading. The pair began the week on a back-foot while printing a 20-pips gap-down opening to 0.6918. However, the recently flashed New Zealand Retail Sales for the third quarter (Q3) helped the quote to fill the difference from Friday’s closing near 0.6940.

NZ Retail Sales favors RBNZ’s bullish bias…

New Zealand (NZ) Retail Sales for Q3 overcome the previous quarter’s -14.6% QoQ contraction while rising 28.00%. Further, the Core Retail Sales also jumped above -13.7% previous declines to 24.1% QoQ.

Read: New Zealand’s Retail Sales unexpectedly jumped 8.3% in Q3, NZD/USD bounces

The data offered additional positives to the Reserve Bank of New Zealand (RBNZ) policymakers who have been bullish off-late. Although the RBNZ Governor Adrian Orr cited fears of the global coronavirus (COVID-19) resurgence in his latest speech, the central banker turned down the negative rates while praising the Pacific economy for its performance to tame the pandemic at home.

Elsewhere, global risks remain depressed amid fears that the US Federal Reserve will have a limited capacity to battle the virus. US Treasury Secretary Steve Mnuchin recently recalled the $500 billion of funds with the Fed while indicating the term expiry. This triggered fears that the US central bank will be left with fewer resources and pushed Fed Chair Jerome Powell and company to resist the demands.

Additionally, the COVID-19 outbreak is worsening in the US and Europe. Wall Street Journal cites a reduction in the daily cases from the record high numbers but a sustained surge in the hospitalization keeps the deadly virus as the major fears for Americans.

Virus vaccines and treatments are battling the bears. Recently Regeneron’s Antibody treatment got a go from the US Food and Drug Administration (FDA) for emergency use while Pfizer is up for the UK’s greenback by this weekend, as per the Telegraph. Also on the positive side could be the US President-elect Joe Biden’s firming up the grip on the American leadership.

Even so, global traders will pay close attention to the November month’s activity numbers for fresh impulse while also keeping an eye over the risk catalysts mentioned above.

Technical analysis

Unless declining back below the 0.6800 mark, comprising multiple highs flashed during the mid-2019 and September 2020, bulls are likely to keep the reins. In doing so, the 0.7000 psychological magnet can become their immediate target. However, a downside break of 10-day SMA, currently near 0.6880 can trigger intraday selling.

Additional important levels

Today last price 0.693
Today Daily Change -9 pips
Today Daily Change % -0.13%
Today daily open 0.6939
Daily SMA20 0.6781
Daily SMA50 0.6693
Daily SMA100 0.6656
Daily SMA200 0.6418
Previous Daily High 0.6952
Previous Daily Low 0.6904
Previous Weekly High 0.6952
Previous Weekly Low 0.6841
Previous Monthly High 0.6726
Previous Monthly Low 0.6546
Daily Fibonacci 38.2% 0.6934
Daily Fibonacci 61.8% 0.6923
Daily Pivot Point S1 0.6911
Daily Pivot Point S2 0.6884
Daily Pivot Point S3 0.6863
Daily Pivot Point R1 0.696
Daily Pivot Point R2 0.698
Daily Pivot Point R3 0.7008



Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.

Feed news

Latest Forex News

Latest Forex News

Editors’ Picks

EUR/USD hits fresh two-month highs amid dollar weakness

EUR/USD has hit new two-month highs above 1.1940 as the dollar resumes its decline. Optimism about the US transition and covid vaccines is weighing on the safe-haven dollar. 


GBP/USD falls toward 1.33 amid Brexit acrimony

GBP/USD is falling toward 1.33 as both the EU and the UK are busy blaming each other for an impasse in Brexit talks. The thorny issues remain fisheries, governance and setting a level playing field.


XAU/USD attempting to bounce up from $1,775 low

Gold futures accelerated heir downtrend from last week highs near $1,900, breaking below the 200-day SMA, at $1,800 area, to hit its lowest prices in nearly five months, at $1,775.

Gold news

Dollar offered ahead of the weekend

Equities are finishing the week on a firm tone, while the US dollar remains heavy. In the Asia Pacific, only Australia and India did not end the week on a firm note.

Read more

Black Friday 2020 Discounts!

Learn to trade with the best! Don't miss the most experienced traders and speakers in FXStreet Premium webinars. Also if you are a Premium member you can get real-time FXS Signals and receive daily market analysis with the best forex insights!

More info